▶ 調査レポート

胸郭出口症候群治療の世界市場(~2026年)

• 英文タイトル:Global Thoracic Outlet Syndrome Treatment Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。胸郭出口症候群治療の世界市場(~2026年) / Global Thoracic Outlet Syndrome Treatment Market Size, Status and Forecast 2020-2026 / MRC2-11QY04845資料のイメージです。• レポートコード:MRC2-11QY04845
• 出版社/出版日:QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、98ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は胸郭出口症候群治療のグローバル市場について調査・分析したレポートです。種類別(外科、投薬、理学療法、その他)市場規模、用途別(病院、診療所、診断センター、その他)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別胸郭出口症候群治療の競争状況、市場シェア
・世界の胸郭出口症候群治療市場:種類別市場規模 2015年-2020年(外科、投薬、理学療法、その他)
・世界の胸郭出口症候群治療市場:種類別市場規模予測 2021年-2026年(外科、投薬、理学療法、その他)
・世界の胸郭出口症候群治療市場:用途別市場規模 2015年-2020年(病院、診療所、診断センター、その他)
・世界の胸郭出口症候群治療市場:用途別市場規模予測 2021年-2026年(病院、診療所、診断センター、その他)
・北米の胸郭出口症候群治療市場分析:米国、カナダ
・ヨーロッパの胸郭出口症候群治療市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの胸郭出口症候群治療市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の胸郭出口症候群治療市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの胸郭出口症候群治療市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Sanofi、Abbott、Bayer、Johnson & Johnson、Boehringer Ingelheim、Bristol-Myers Squibb、Daiichi Sankyo、Endo Pharmaceuticals、SteriMax、Upsher Smith Laboratories、Mallinckrodt、Orient Pharma
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Thoracic outlet syndrome is a group of heterogeneous and disabling upper-extremity disorders that occur due to extrinsic compression of neurovascular structures between the clavicle and the first rib. There are three distinct types of thoracic outlet syndrome viz. neurogenic thoracic outlet syndrome, venous thoracic outlet syndrome, and arterial thoracic outlet syndrome.
Neurogenic thoracic outlet syndrome is most common, i.e., it constitutes around 85%-90% of thoracic outlet syndrome cases. Venous thoracic outlet syndrome constitutes around 10%-15% of thoracic outlet syndrome cases, whereas arterial thoracic outlet syndrome is found in 2%-5% of thoracic outlet syndrome cases.

Market Analysis and Insights: Global Thoracic Outlet Syndrome Treatment Market
The global Thoracic Outlet Syndrome Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Thoracic Outlet Syndrome Treatment Scope and Market Size
Thoracic Outlet Syndrome Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Thoracic Outlet Syndrome Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Sanofi
Abbott
Bayer
Johnson & Johnson
Boehringer Ingelheim
Bristol-Myers Squibb
Daiichi Sankyo
Endo Pharmaceuticals
SteriMax
Upsher Smith Laboratories
Mallinckrodt
Orient Pharma

Market segment by Type, the product can be split into
Surgery
Medication
Physical Therapy
Others
Market segment by Application, split into
Hospitals
Clinics
Diagnostic Centers
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Thoracic Outlet Syndrome Treatment Revenue
1.4 Market by Type
1.4.1 Global Thoracic Outlet Syndrome Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Surgery
1.4.3 Medication
1.4.4 Physical Therapy
1.4.5 Others
1.5 Market by Application
1.5.1 Global Thoracic Outlet Syndrome Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Diagnostic Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Thoracic Outlet Syndrome Treatment Market Perspective (2015-2026)
2.2 Global Thoracic Outlet Syndrome Treatment Growth Trends by Regions
2.2.1 Thoracic Outlet Syndrome Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Thoracic Outlet Syndrome Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Thoracic Outlet Syndrome Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Thoracic Outlet Syndrome Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Thoracic Outlet Syndrome Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Thoracic Outlet Syndrome Treatment Players by Market Size
3.1.1 Global Top Thoracic Outlet Syndrome Treatment Players by Revenue (2015-2020)
3.1.2 Global Thoracic Outlet Syndrome Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Thoracic Outlet Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Thoracic Outlet Syndrome Treatment Market Concentration Ratio
3.2.1 Global Thoracic Outlet Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Thoracic Outlet Syndrome Treatment Revenue in 2019
3.3 Thoracic Outlet Syndrome Treatment Key Players Head office and Area Served
3.4 Key Players Thoracic Outlet Syndrome Treatment Product Solution and Service
3.5 Date of Enter into Thoracic Outlet Syndrome Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Thoracic Outlet Syndrome Treatment Historic Market Size by Type (2015-2020)
4.2 Global Thoracic Outlet Syndrome Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Thoracic Outlet Syndrome Treatment Market Size by Application (2015-2020)
5.2 Global Thoracic Outlet Syndrome Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Thoracic Outlet Syndrome Treatment Market Size (2015-2020)
6.2 Thoracic Outlet Syndrome Treatment Key Players in North America (2019-2020)
6.3 North America Thoracic Outlet Syndrome Treatment Market Size by Type (2015-2020)
6.4 North America Thoracic Outlet Syndrome Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Thoracic Outlet Syndrome Treatment Market Size (2015-2020)
7.2 Thoracic Outlet Syndrome Treatment Key Players in Europe (2019-2020)
7.3 Europe Thoracic Outlet Syndrome Treatment Market Size by Type (2015-2020)
7.4 Europe Thoracic Outlet Syndrome Treatment Market Size by Application (2015-2020)

8 China
8.1 China Thoracic Outlet Syndrome Treatment Market Size (2015-2020)
8.2 Thoracic Outlet Syndrome Treatment Key Players in China (2019-2020)
8.3 China Thoracic Outlet Syndrome Treatment Market Size by Type (2015-2020)
8.4 China Thoracic Outlet Syndrome Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Thoracic Outlet Syndrome Treatment Market Size (2015-2020)
9.2 Thoracic Outlet Syndrome Treatment Key Players in Japan (2019-2020)
9.3 Japan Thoracic Outlet Syndrome Treatment Market Size by Type (2015-2020)
9.4 Japan Thoracic Outlet Syndrome Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Thoracic Outlet Syndrome Treatment Market Size (2015-2020)
10.2 Thoracic Outlet Syndrome Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Thoracic Outlet Syndrome Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Thoracic Outlet Syndrome Treatment Market Size by Application (2015-2020)

11 India
11.1 India Thoracic Outlet Syndrome Treatment Market Size (2015-2020)
11.2 Thoracic Outlet Syndrome Treatment Key Players in India (2019-2020)
11.3 India Thoracic Outlet Syndrome Treatment Market Size by Type (2015-2020)
11.4 India Thoracic Outlet Syndrome Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Thoracic Outlet Syndrome Treatment Market Size (2015-2020)
12.2 Thoracic Outlet Syndrome Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Thoracic Outlet Syndrome Treatment Market Size by Type (2015-2020)
12.4 Central & South America Thoracic Outlet Syndrome Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Sanofi
13.1.1 Sanofi Company Details
13.1.2 Sanofi Business Overview
13.1.3 Sanofi Thoracic Outlet Syndrome Treatment Introduction
13.1.4 Sanofi Revenue in Thoracic Outlet Syndrome Treatment Business (2015-2020))
13.1.5 Sanofi Recent Development
13.2 Abbott
13.2.1 Abbott Company Details
13.2.2 Abbott Business Overview
13.2.3 Abbott Thoracic Outlet Syndrome Treatment Introduction
13.2.4 Abbott Revenue in Thoracic Outlet Syndrome Treatment Business (2015-2020)
13.2.5 Abbott Recent Development
13.3 Bayer
13.3.1 Bayer Company Details
13.3.2 Bayer Business Overview
13.3.3 Bayer Thoracic Outlet Syndrome Treatment Introduction
13.3.4 Bayer Revenue in Thoracic Outlet Syndrome Treatment Business (2015-2020)
13.3.5 Bayer Recent Development
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Details
13.4.2 Johnson & Johnson Business Overview
13.4.3 Johnson & Johnson Thoracic Outlet Syndrome Treatment Introduction
13.4.4 Johnson & Johnson Revenue in Thoracic Outlet Syndrome Treatment Business (2015-2020)
13.4.5 Johnson & Johnson Recent Development
13.5 Boehringer Ingelheim
13.5.1 Boehringer Ingelheim Company Details
13.5.2 Boehringer Ingelheim Business Overview
13.5.3 Boehringer Ingelheim Thoracic Outlet Syndrome Treatment Introduction
13.5.4 Boehringer Ingelheim Revenue in Thoracic Outlet Syndrome Treatment Business (2015-2020)
13.5.5 Boehringer Ingelheim Recent Development
13.6 Bristol-Myers Squibb
13.6.1 Bristol-Myers Squibb Company Details
13.6.2 Bristol-Myers Squibb Business Overview
13.6.3 Bristol-Myers Squibb Thoracic Outlet Syndrome Treatment Introduction
13.6.4 Bristol-Myers Squibb Revenue in Thoracic Outlet Syndrome Treatment Business (2015-2020)
13.6.5 Bristol-Myers Squibb Recent Development
13.7 Daiichi Sankyo
13.7.1 Daiichi Sankyo Company Details
13.7.2 Daiichi Sankyo Business Overview
13.7.3 Daiichi Sankyo Thoracic Outlet Syndrome Treatment Introduction
13.7.4 Daiichi Sankyo Revenue in Thoracic Outlet Syndrome Treatment Business (2015-2020)
13.7.5 Daiichi Sankyo Recent Development
13.8 Endo Pharmaceuticals
13.8.1 Endo Pharmaceuticals Company Details
13.8.2 Endo Pharmaceuticals Business Overview
13.8.3 Endo Pharmaceuticals Thoracic Outlet Syndrome Treatment Introduction
13.8.4 Endo Pharmaceuticals Revenue in Thoracic Outlet Syndrome Treatment Business (2015-2020)
13.8.5 Endo Pharmaceuticals Recent Development
13.9 SteriMax
13.9.1 SteriMax Company Details
13.9.2 SteriMax Business Overview
13.9.3 SteriMax Thoracic Outlet Syndrome Treatment Introduction
13.9.4 SteriMax Revenue in Thoracic Outlet Syndrome Treatment Business (2015-2020)
13.9.5 SteriMax Recent Development
13.10 Upsher Smith Laboratories
13.10.1 Upsher Smith Laboratories Company Details
13.10.2 Upsher Smith Laboratories Business Overview
13.10.3 Upsher Smith Laboratories Thoracic Outlet Syndrome Treatment Introduction
13.10.4 Upsher Smith Laboratories Revenue in Thoracic Outlet Syndrome Treatment Business (2015-2020)
13.10.5 Upsher Smith Laboratories Recent Development
13.11 Mallinckrodt
10.11.1 Mallinckrodt Company Details
10.11.2 Mallinckrodt Business Overview
10.11.3 Mallinckrodt Thoracic Outlet Syndrome Treatment Introduction
10.11.4 Mallinckrodt Revenue in Thoracic Outlet Syndrome Treatment Business (2015-2020)
10.11.5 Mallinckrodt Recent Development
13.12 Orient Pharma
10.12.1 Orient Pharma Company Details
10.12.2 Orient Pharma Business Overview
10.12.3 Orient Pharma Thoracic Outlet Syndrome Treatment Introduction
10.12.4 Orient Pharma Revenue in Thoracic Outlet Syndrome Treatment Business (2015-2020)
10.12.5 Orient Pharma Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Thoracic Outlet Syndrome Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Thoracic Outlet Syndrome Treatment Revenue
Table 3. Ranking of Global Top Thoracic Outlet Syndrome Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Thoracic Outlet Syndrome Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Surgery
Table 6. Key Players of Medication
Table 7. Key Players of Physical Therapy
Table 8. Key Players of Others
Table 9. Global Thoracic Outlet Syndrome Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Thoracic Outlet Syndrome Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Thoracic Outlet Syndrome Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Thoracic Outlet Syndrome Treatment Market Share by Regions (2015-2020)
Table 13. Global Thoracic Outlet Syndrome Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Thoracic Outlet Syndrome Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Thoracic Outlet Syndrome Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Thoracic Outlet Syndrome Treatment Players
Table 20. Global Thoracic Outlet Syndrome Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Thoracic Outlet Syndrome Treatment Market Share by Players (2015-2020)
Table 22. Global Top Thoracic Outlet Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Thoracic Outlet Syndrome Treatment as of 2019)
Table 23. Global Thoracic Outlet Syndrome Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Thoracic Outlet Syndrome Treatment Product Solution and Service
Table 26. Date of Enter into Thoracic Outlet Syndrome Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Thoracic Outlet Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Thoracic Outlet Syndrome Treatment Market Size Share by Type (2015-2020)
Table 30. Global Thoracic Outlet Syndrome Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Thoracic Outlet Syndrome Treatment Market Size Share by Application (2015-2020)
Table 32. Global Thoracic Outlet Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Thoracic Outlet Syndrome Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Thoracic Outlet Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Thoracic Outlet Syndrome Treatment Market Share (2019-2020)
Table 36. North America Thoracic Outlet Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Thoracic Outlet Syndrome Treatment Market Share by Type (2015-2020)
Table 38. North America Thoracic Outlet Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Thoracic Outlet Syndrome Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Thoracic Outlet Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Thoracic Outlet Syndrome Treatment Market Share (2019-2020)
Table 42. Europe Thoracic Outlet Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Thoracic Outlet Syndrome Treatment Market Share by Type (2015-2020)
Table 44. Europe Thoracic Outlet Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Thoracic Outlet Syndrome Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Thoracic Outlet Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Thoracic Outlet Syndrome Treatment Market Share (2019-2020)
Table 48. China Thoracic Outlet Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Thoracic Outlet Syndrome Treatment Market Share by Type (2015-2020)
Table 50. China Thoracic Outlet Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Thoracic Outlet Syndrome Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Thoracic Outlet Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Thoracic Outlet Syndrome Treatment Market Share (2019-2020)
Table 54. Japan Thoracic Outlet Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Thoracic Outlet Syndrome Treatment Market Share by Type (2015-2020)
Table 56. Japan Thoracic Outlet Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Thoracic Outlet Syndrome Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Thoracic Outlet Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Thoracic Outlet Syndrome Treatment Market Share (2019-2020)
Table 60. Southeast Asia Thoracic Outlet Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Thoracic Outlet Syndrome Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Thoracic Outlet Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Thoracic Outlet Syndrome Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Thoracic Outlet Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Thoracic Outlet Syndrome Treatment Market Share (2019-2020)
Table 66. India Thoracic Outlet Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Thoracic Outlet Syndrome Treatment Market Share by Type (2015-2020)
Table 68. India Thoracic Outlet Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Thoracic Outlet Syndrome Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Thoracic Outlet Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Thoracic Outlet Syndrome Treatment Market Share (2019-2020)
Table 72. Central & South America Thoracic Outlet Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Thoracic Outlet Syndrome Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Thoracic Outlet Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Thoracic Outlet Syndrome Treatment Market Share by Application (2015-2020)
Table 76. Sanofi Company Details
Table 77. Sanofi Business Overview
Table 78. Sanofi Product
Table 79. Sanofi Revenue in Thoracic Outlet Syndrome Treatment Business (2015-2020) (Million US$)
Table 80. Sanofi Recent Development
Table 81. Abbott Company Details
Table 82. Abbott Business Overview
Table 83. Abbott Product
Table 84. Abbott Revenue in Thoracic Outlet Syndrome Treatment Business (2015-2020) (Million US$)
Table 85. Abbott Recent Development
Table 86. Bayer Company Details
Table 87. Bayer Business Overview
Table 88. Bayer Product
Table 89. Bayer Revenue in Thoracic Outlet Syndrome Treatment Business (2015-2020) (Million US$)
Table 90. Bayer Recent Development
Table 91. Johnson & Johnson Company Details
Table 92. Johnson & Johnson Business Overview
Table 93. Johnson & Johnson Product
Table 94. Johnson & Johnson Revenue in Thoracic Outlet Syndrome Treatment Business (2015-2020) (Million US$)
Table 95. Johnson & Johnson Recent Development
Table 96. Boehringer Ingelheim Company Details
Table 97. Boehringer Ingelheim Business Overview
Table 98. Boehringer Ingelheim Product
Table 99. Boehringer Ingelheim Revenue in Thoracic Outlet Syndrome Treatment Business (2015-2020) (Million US$)
Table 100. Boehringer Ingelheim Recent Development
Table 101. Bristol-Myers Squibb Company Details
Table 102. Bristol-Myers Squibb Business Overview
Table 103. Bristol-Myers Squibb Product
Table 104. Bristol-Myers Squibb Revenue in Thoracic Outlet Syndrome Treatment Business (2015-2020) (Million US$)
Table 105. Bristol-Myers Squibb Recent Development
Table 106. Daiichi Sankyo Company Details
Table 107. Daiichi Sankyo Business Overview
Table 108. Daiichi Sankyo Product
Table 109. Daiichi Sankyo Revenue in Thoracic Outlet Syndrome Treatment Business (2015-2020) (Million US$)
Table 110. Daiichi Sankyo Recent Development
Table 111. Endo Pharmaceuticals Business Overview
Table 112. Endo Pharmaceuticals Product
Table 113. Endo Pharmaceuticals Company Details
Table 114. Endo Pharmaceuticals Revenue in Thoracic Outlet Syndrome Treatment Business (2015-2020) (Million US$)
Table 115. Endo Pharmaceuticals Recent Development
Table 116. SteriMax Company Details
Table 117. SteriMax Business Overview
Table 118. SteriMax Product
Table 119. SteriMax Revenue in Thoracic Outlet Syndrome Treatment Business (2015-2020) (Million US$)
Table 120. SteriMax Recent Development
Table 121. Upsher Smith Laboratories Company Details
Table 122. Upsher Smith Laboratories Business Overview
Table 123. Upsher Smith Laboratories Product
Table 124. Upsher Smith Laboratories Revenue in Thoracic Outlet Syndrome Treatment Business (2015-2020) (Million US$)
Table 125. Upsher Smith Laboratories Recent Development
Table 126. Mallinckrodt Company Details
Table 127. Mallinckrodt Business Overview
Table 128. Mallinckrodt Product
Table 129. Mallinckrodt Revenue in Thoracic Outlet Syndrome Treatment Business (2015-2020) (Million US$)
Table 130. Mallinckrodt Recent Development
Table 131. Orient Pharma Company Details
Table 132. Orient Pharma Business Overview
Table 133. Orient Pharma Product
Table 134. Orient Pharma Revenue in Thoracic Outlet Syndrome Treatment Business (2015-2020) (Million US$)
Table 135. Orient Pharma Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Thoracic Outlet Syndrome Treatment Market Share by Type: 2020 VS 2026
Figure 2. Surgery Features
Figure 3. Medication Features
Figure 4. Physical Therapy Features
Figure 5. Others Features
Figure 6. Global Thoracic Outlet Syndrome Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Diagnostic Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Thoracic Outlet Syndrome Treatment Report Years Considered
Figure 12. Global Thoracic Outlet Syndrome Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Thoracic Outlet Syndrome Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Thoracic Outlet Syndrome Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Thoracic Outlet Syndrome Treatment Market Share by Players in 2019
Figure 17. Global Top Thoracic Outlet Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Thoracic Outlet Syndrome Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Thoracic Outlet Syndrome Treatment Revenue in 2019
Figure 19. North America Thoracic Outlet Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Thoracic Outlet Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Thoracic Outlet Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Thoracic Outlet Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Thoracic Outlet Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Thoracic Outlet Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Thoracic Outlet Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed